Madison, CT, United States of America

He Zhao

This inventor holds 34 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in C5a Receptor Modulators. Top assignees: Neurogen Corporation, Zenith Epigenetics Corp., Ultragenyx Pharmaceutical Inc.. Active years: 2001-2022.

USPTO Granted Patents = 34 

% Patents Active = 32.4

 

 

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 222(Granted Patents)


Location History:

  • Branford, CT (US) (2001 - 2012)
  • Madison, CT (US) (2007 - 2022)

Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
KDM1A Inhibitors
Bromodomain Inhibitors
Sialic Acid Analogs
C5a Receptor Modulators
Heterocyclic Compounds
Amino Methyl Imidazoles
Substituted Biaryl Amides
High Affinity Molecules
Tetrahydroisoquinolines
Dopamine Receptor Ligands
Aryl Imidazoles
4,5-Disubstituted Pyrimidines
34 patents (USPTO):Explore Patents

Title: Inventor He Zhao: Pioneering Innovations in Madison

Introduction: He Zhao is a distinguished inventor based in Madison, CT, known for his groundbreaking contributions to various technological fields.

Latest Patents: He Zhao holds several patents in the areas of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, He Zhao has worked with leading research institutions and universities to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: He Zhao has collaborated with top companies and fellow inventors to bring his ideas to life, fostering a culture of innovation and collaboration in the process.

Conclusion: He Zhao's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…